Synteract

Synteract is an innovative CRO that provides full-service support from Phase I to Phase IV for biopharmaceutical companies, helping to bring new drugs to market. Synteract combines operational excellence, therapeutic expertise, and the right technology to meet each client’s clinical development needs. For nearly 30 years, CT has maintained a leading position in the comprehensive treatment of pediatrics, surpassing core areas such as pediatrics, oncology, and trigeminal neuroscience.